All News

This week’s Cooking with CURE recipe for Chipotle Corn Salad, courtesy of the oncology dietitians at the John Theurer Cancer Center, is a perfect pantry-staple dish that’s packed with many vitamins and minerals, including A, E, iron and magnesium.

"Age is an issue of mind over matter. If you don't mind, it doesn't matter."

In this episode of the “CURE Talks Cancer” podcast we interview genetic counselor Dana Farengo Clark on how genetic counseling is adjusting to the new normal and shifting into the virtual era of cancer care.

Here is a list of the recent trial initiations that occurred within the cancer space in June.

A new tool analyzes patterns of RNA expressed from genes, pinpointing more patients with cancer who can benefit from immunotherapies and targeted drugs.

The Food and Drug Administration approved Keytruda to treat patients with recurrent or metastatic cutaneous squamous cell carcinoma that cannot be treated with surgery or radiation.

Ten years ago, as I was approaching my first follow-up scan, I asked a seasoned cancer survivor if the anxiety of going through these rituals ever got easier. Without hesitation, she smiled and said "no."

Immunotherapy could help a segment of patients with metastatic prostate cancer, a study found.

For the treatment of patients with non-small cell lung cancer, the field has seen one approval after the other, but for one expert this is a sign that things are moving too fast to be applied in a "rational trial strategy".

New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.

The Food and Drug Administration has had a busy couple of weeks, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

“Anyone who met my mother was touched by her spirit. She challenged people to be curious, to seek more, to learn more and to challenge themselves,” LaTour’s daughter, Kirtley Perkins, wrote on Facebook.

Immunotherapy with Keytruda shows promise in advanced uncommon cancers in which new treatment options are needed.

Regulation changes could eliminate barriers to potentially lifesaving CAR-T cell immunotherapy for patients covered by Medicare or Medicaid.

In order to combat resistance to certain treatments for patients with metastatic breast cancer, researchers look to a novel combination of pyrotinib plus Xeloda to help increase progression-free survival in patients.

Support for cancer patients and survivors comes in all shapes and sizes, but sometimes the good vibes, encouragement and positivity can go too far

The Food and Drug Administration granted accelerated approval to Xpovio for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who have undergone two prior therapies.

A variety of novel treatments, including immunotherapies, extend life for patients with advanced kidney cancer.

A breast cancer survivor talks about how she went about enjoying the summer to find the right swimsuit for her after her cancer journey included a mastectomy.

From a study showing a popular cancer side effect management steroid decreasing the risk of death for patients in the hospital with COVID-19 to a new liquid biopsy test detecting lingering cancer in DNA, here’s what’s making the headlines in the cancer space this week.

“The relapse-free survival curves for both treatment arms appear to be reaching a plateau, which is a good sign if we are talking about cure,” said lead study author Dr. Axel Hauschild.

Andrea Dwyer spoke with CURE® about the symposium and why it is important to raise global awareness around the increasing rate of early-age onset colorectal cancer.

The Food and Drug Administration approved Tazverik for adults with relapsed or refractory follicular lymphoma whose tumors are positive for an EZH2 mutation and have received treatment with at least two systemic therapies, as well as patients who have no other treatment options.

Writing about the cancer journey and sharing your story is vulnerable and challenging, but the experience is often cathartic and necessary.

The "Cooking With CURE Recipe Series" continues with an easy and healthy snack recipe for granola bars to give you that extra boost in the day.

According to data presented at the 2020 ASCO Virtual Scientific Program, increasing the dose of thoracic radiotherapy from the standard measurement of dosing improved survival in patients with limited-disease small cell lung cancer.

Traveling with cancer during a pandemic requires some planning. Here's how I did it safely.

According to lead study author Dr. Luis Paz-Ares, study findings confirm the use of the immunotherapy Imfinzi in combination with etoposide plus cisplatin or carboplatin (EP) as a new frontline standard of care for this patient population.

The Food and Drug Administration approved the second biomarker-based indication for Keytruda to treat adult and pediatric patients with unresectable or metastatic TMB-H solid tumors across cancer types, including rare cancers.

After a median follow-up of 13.3 months, the median overall response rate across all patients who received idecabtagene vicleucel (ide-cel) was 73%, including a complete response of 33%.